This is another type of muscular dystrophy. It causes weakness in the muscles of the face, shoulders, and upper arms. Symptoms usually start in childhood or early adulthood.
Every report comes from a Lived member, sent anonymously.
Have you tried Exercise Therapy for Facioscapulohumeral Muscular Dystrophy (FSHD)?
Facioscapulohumeral muscular dystrophy (FSHD) is an inherited muscle disease that causes slowly progressive weakness and wasting. Its long name describes where it usually starts: the face (facio), the muscles that hold the shoulder blades in place (scapulo) and the upper arms (humeral). It is one of the more common muscular dystrophies, affecting roughly 1 in 20,000 people. Facial weakness can make it hard to whistle, drink through a straw, close the eyes tightly or turn up the corners of the mouth when smiling. Weak shoulder muscles let the shoulder blades stick out from the back (called scapular winging) and make it difficult to lift the arms overhead. Over years, weakness can spread to the abdomen, hips and lower legs. A hallmark of FSHD is that it is often uneven, affecting one side of the body more than the other. Symptoms usually appear in the teenage years, but the range is wide. Some people are not aware of weakness until middle age, while a rare, more severe form begins in infancy or early childhood.
FSHD is caused by genetic changes near the end of chromosome 4, in a stretch of repeated DNA called D4Z4. Normally this region is chemically switched off. In FSHD it is not switched off fully, which allows a gene called DUX4 to become active in muscle, where it is normally silent. How this damages muscle is still being worked out, but active DUX4 is the target of most current research. There are two genetic types that look the same in practice. FSHD1, about 95 percent of cases, happens when the D4Z4 region is shorter than usual. It is inherited in an autosomal dominant pattern: a parent with FSHD1 has a 50 percent chance of passing it to each child. Roughly 10 to 30 percent of people with FSHD1 are the first in their family to have it. FSHD2 usually results from a change in a different gene, most often SMCHD1, combined with a particular version of chromosome 4, so it is often inherited from two parents who are both unaffected. FSHD is not caused by anything a person did. Family members with the same genetic change can be affected very differently, from barely noticeable weakness to significant disability.
A neurologist, often one who specializes in neuromuscular disease, usually suspects FSHD from the pattern of weakness: facial involvement, winged shoulder blades and uneven strength between the two sides. A family history helps but is not required. Genetic testing confirms the diagnosis. For FSHD1, it measures the size of the D4Z4 region and is highly accurate. FSHD2 needs different tests that look at how much the region is switched off and for changes in genes such as SMCHD1. A muscle biopsy or electromyography (a test of the electrical activity in muscles) is now mainly used when the picture is unclear or testing is negative. After diagnosis, a few checks look for related problems. An eye specialist can examine the retina (the light-sensing layer at the back of the eye) for leaky blood vessels, a rare complication that can be treated before it harms vision; this matters most for people with a very short D4Z4 region. Children with early-onset FSHD should have hearing tests, because unnoticed hearing loss can affect language development. People with more severe weakness may have breathing tests. Routine heart screening is not needed unless there are heart symptoms.
No medicine has yet been shown to slow or stop FSHD. A large trial of losmapimod, an experimental drug designed to reduce DUX4 activity, reported in 2026 that it did not improve arm reach or strength compared with placebo, and other approaches are in clinical trials. Treatment today aims to preserve function, prevent complications and manage symptoms. A physical therapist can design an exercise plan that keeps people active without overworking weak muscles. Low-intensity aerobic exercise, such as walking, cycling or swimming, appears safe and may help fitness. Occupational therapy offers practical ways to manage daily tasks with weaker arms. For foot drop (weakness that makes the front of the foot hard to lift), an ankle-foot orthosis, a lightweight brace worn in the shoe, can make walking steadier and reduce falls. Canes, scooters or a wheelchair can extend range and independence when walking becomes harder. For some people with severe shoulder blade winging, surgery that fixes the shoulder blade to the chest wall (scapular fixation) can improve how high they can raise their arms. It suits only carefully selected people and requires a period of rehabilitation afterward, so it is a decision for an experienced surgical team. Pain in the shoulders, back and legs is common and is treated with physical therapy and medication. If the eyes do not close completely during sleep, lubricating drops or ointment, or gently taping the eyelids shut at night, protects the surface of the eye. Breathing support from a ventilation device is needed only in a small number of people with severe weakness.
FSHD usually progresses slowly over decades, sometimes with long stable periods and occasional spells of faster change. Most people keep walking throughout life, though about 1 in 5 eventually need a wheelchair, at least for longer distances. Most people with FSHD have a normal or near-normal lifespan; the rare early-childhood form tends to be more severe, and data on survival in that group are limited. Day to day, the main effects are on overhead reaching, lifting, carrying and, for many, walking and balance. Facial weakness can flatten expressions or make a smile look uneven, so others may find emotions harder to read. Fatigue and chronic pain are common and are worth treating as seriously as weakness itself. Work, home and car adaptations often make a large difference. Regular follow-up with a neuromuscular team, often yearly, tracks strength, mobility, pain and breathing, and adjusts therapy, braces and equipment as needs change. Because FSHD is genetic, many people also meet with a genetic counselor to understand what it means for children and other relatives. Patient registries and support organizations can connect people with clinical trials.
Arrange an evaluation with a neurologist if you notice weakness in the face, difficulty raising your arms, shoulder blades that stick out, or a foot that catches or slaps when you walk, especially if a relative has FSHD. Contact your care team promptly if you develop new or worsening shortness of breath or breathing problems during sleep, more frequent falls, a change in vision, or eye pain or redness from eyes not closing at night. Let them know too if pain or fatigue is limiting daily life, or if a child with FSHD seems to have trouble hearing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Facioscapulohumeral Muscular Dystrophy (FSHD) is like, what's helped you, or ask the community a question.